|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�������������Ƥ���ۺ��� |
|
���ɫ������� |
|
��Ƥ���Ѷ��� |
| ��������������� | |
|
������ |
|
��־�� |
| PubMed | |
|
Article by |
|
Article by |
�������������Ƥ���ۺ������о���չ
������, ��־��
�㶫ҽѧԺ����ҽԺƤ���� տ�� 524001
��Ƥ���Ѷ������������������Ƥ���ۺ����IJ���,����ֱ��������������(��)��Ϊ����ԭ�����Ƥ�ɽ�.�������������Ƥ���ۺ����÷��ڶ�ͯ�������ڳ���,���������ѭ���б�Ƥ���Ѷ��ؿ���Ũ�Ƚϸߺ������л����й����������ǿ�й�.���������Ŀǰ��Ҫ�������ٴ�,ȷ�����н��ɫ��������ɾ������ͱ�Ƥ���Ѷ��ؼ��.�ͦ�������ø��������������Ч.��ͯ������������Ϊ3%��4%.
[2] Ladhani S, Evans RW. Staphylococcal scalded skin syndrome. Arch Dis Child, 1998, 78(1): 85-88.
[3] Fitzpatrick TB, et al. Dermatology in general medicine.4th ed. New York: McGraw-Hill, 1993.601-605.
[4] Acland KM, Darvay A, Griffin C, et al. Staphylococcal scalded skin syndrome in an adult associated with methicillin-resistant Staphylococcus aureus. Br J Dermatol, 1999,140(3): 518-520.
[5] Rago JV, Vath GM, Tripp TJ, et al. Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte-stimulating hormones. Infect Immun,2000,68(4): 2366-2368.
[6] Vath GM, Earhart CA, Monie DD, et al. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry, 1999,38(32): 10239-10246.
[7] Lina G, Gillet Y, Vandenesch F, et al. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis, 1997, 25 (6): 1369-1373.
[8] Ladhani S, Joannou CL, Lochrie DP, et al. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scaldedskin syndrome. Clin Microbiol Rev, 1999, 12(2): 224-242.
[9] Rago JV, Vath GM, Bohach GA, et al. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA). J Immunol, 2000, 164(4): 2207-2213.
[10] Ninomiya J, Ito Y, Takiuchi I. Purification of protease from a mixture of exfoliative toxin and newborn-mouse epidermis. Infect Immtm, 2000, 68(9): 5044-5049.
[11] Monday SR, Vath GM, Ferens WA, et al. Unique superantigen activity of staphylococcal exfoliative toxins. J Immunol, 1999, 162(8): 4550-4559.
[12] Plano LR, Gutman DM, Woischnik M, et al. Recombinant Staphylococcus anreus exfoliative toxins are not bacterial superantigens. Infect Immun,2000, 68(5): 3048-3052.
[13] Leaute-Labreze C, Sarlangue J, Pedespan L, et al. Neonatal staphylococcal epidermolysis due to maternal-fetal transmission. Ann Dermatol Venereol, 1999,126(10): 713-715.
[14] Greenwood JE, Dunn KW, Davenport PJ. Experience with severe extensive blistering skin disease in a paediatric bums unit. Bums,2000,26(1):82-87.